NEVIRAPINE is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Nevirapine.
| Product ID | 69097-403_47275ac6-0124-46d2-9ef4-4338aa27c05d |
| NDC | 69097-403 |
| Product Type | Human Prescription Drug |
| Proprietary Name | NEVIRAPINE |
| Generic Name | Nevirapine |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-10-15 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA206448 |
| Labeler Name | Cipla USA Inc. |
| Substance Name | NEVIRAPINE |
| Active Ingredient Strength | 400 mg/1 |
| Pharm Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2015-10-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA206448 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-10-15 |
| Marketing End Date | 2019-12-31 |
| Marketing Category | ANDA |
| Application Number | ANDA206448 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-10-15 |
| Marketing End Date | 2019-12-31 |
| Ingredient | Strength |
|---|---|
| NEVIRAPINE | 400 mg/1 |
| SPL SET ID: | 2407e468-d65b-4842-9316-73433a8b8c14 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-4050 | Nevirapine | nevirapine |
| 0378-4890 | Nevirapine | nevirapine |
| 0378-6950 | Nevirapine | nevirapine |
| 0781-5893 | Nevirapine | Nevirapine |
| 31722-505 | Nevirapine | Nevirapine |
| 33342-004 | Nevirapine | Nevirapine |
| 33342-238 | NEVIRAPINE | NEVIRAPINE |
| 42571-131 | NEVIRAPINE | NEVIRAPINE |
| 51991-331 | Nevirapine | NEVIRAPINE |
| 53104-0166 | nevirapine | nevirapine |
| 53808-0680 | Nevirapine | nevirapine |
| 53808-1069 | nevirapine | nevirapine |
| 61442-470 | Nevirapine | Nevirapine |
| 64380-709 | Nevirapine | Nevirapine |
| 65162-209 | Nevirapine | Nevirapine |
| 69097-403 | NEVIRAPINE | NEVIRAPINE |
| 69097-233 | nevirapine | nevirapine |
| 65862-057 | Nevirapine | Nevirapine |
| 65862-027 | Nevirapine | Nevirapine |
| 65862-932 | NEVIRAPINE | NEVIRAPINE |
| 65862-933 | NEVIRAPINE | NEVIRAPINE |
| 47781-317 | Nevirapine Extended Release | nevirapine |
| 0597-0046 | Viramune | nevirapine |
| 0597-0047 | Viramune | nevirapine |
| 0597-0123 | Viramune | nevirapine |
| 53808-0808 | Viramune | nevirapine |